WallStreetZenWallStreetZen

NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for TNXP

Based on 1 analyst offering 12 month price targets for Tonix Pharmaceuticals Holding Corp

Min Forecast
$70.00+292.82%
Avg Forecast
$70.00+292.82%
Max Forecast
$70.00+292.82%

Should I buy or sell TNXP stock?

Based on 1 analyst offering ratings for Tonix Pharmaceuticals Holding Corp.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TNXP's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates TNXP as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their TNXP stock forecasts and price targets.

TNXP stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-20

1 of 1

Forecast return on equity

Is TNXP forecast to generate an efficient return?

Company
N/A
Industry
144.6%
Market
80.02%

Forecast return on assets

Is TNXP forecast to generate an efficient return on assets?

Company
N/A
Industry
35.78%

TNXP earnings per share forecast

What is TNXP's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$14.16
Avg 2 year Forecast
-$6.24
Avg 3 year Forecast
-$0.53

TNXP revenue forecast

What is TNXP's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$11.1M+9.97%
Avg 2 year Forecast
$98.7M+877.81%
Avg 3 year Forecast
$131.5M+1,202.75%
TNXP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TNXP revenue growth forecast

How is TNXP forecast to perform vs Biotechnology companies and vs the US market?

Company
144.29%
Industry
64.34%
Market
10.27%
TNXP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TNXP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TNXP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TNXP$17.82$70.00+292.82%Buy
CTNM$4.41$23.75+438.55%Strong Buy
BHST$6.55$13.00+98.47%Strong Buy
RAPT$0.88$7.00+696.36%Strong Buy
ALEC$1.14$4.10+259.65%Hold
View Top Biotech Stocks

Tonix Pharmaceuticals Holding Stock Forecast FAQ

Is Tonix Pharmaceuticals Holding Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: TNXP) stock is to Buy TNXP stock.

Out of 1 analyst, 0 (0%) are recommending TNXP as a Strong Buy, 1 (100%) are recommending TNXP as a Buy, 0 (0%) are recommending TNXP as a Hold, 0 (0%) are recommending TNXP as a Sell, and 0 (0%) are recommending TNXP as a Strong Sell.

If you're new to stock investing, here's how to buy Tonix Pharmaceuticals Holding stock.

What is TNXP's earnings growth forecast for 2025-2027?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.38%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.58%.

Tonix Pharmaceuticals Holding's earnings in 2025 is -$130,036,000.On average, 2 Wall Street analysts forecast TNXP's earnings for 2025 to be -$91,117,915, with the lowest TNXP earnings forecast at -$105,725,095, and the highest TNXP earnings forecast at -$76,510,735. On average, 2 Wall Street analysts forecast TNXP's earnings for 2026 to be -$40,121,483, with the lowest TNXP earnings forecast at -$50,192,072, and the highest TNXP earnings forecast at -$30,050,894.

In 2027, TNXP is forecast to generate -$3,410,487 in earnings, with the lowest earnings forecast at -$3,410,487 and the highest earnings forecast at -$3,410,487.

What is TNXP's revenue growth forecast for 2025-2027?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's forecast annual revenue growth rate of 144.29% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.34%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.27%.

Tonix Pharmaceuticals Holding's revenue in 2025 is $10,094,000.On average, 2 Wall Street analysts forecast TNXP's revenue for 2025 to be $71,427,179, with the lowest TNXP revenue forecast at $71,427,179, and the highest TNXP revenue forecast at $71,427,179. On average, 2 Wall Street analysts forecast TNXP's revenue for 2026 to be $635,122,755, with the lowest TNXP revenue forecast at $201,411,775, and the highest TNXP revenue forecast at $1,068,833,734.

In 2027, TNXP is forecast to generate $846,186,852 in revenue, with the lowest revenue forecast at $846,186,852 and the highest revenue forecast at $846,186,852.

What is TNXP's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TNXP) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 35.78%.

What is TNXP's Price Target?

According to 1 Wall Street analyst that have issued a 1 year TNXP price target, the average TNXP price target is $70.00, with the highest TNXP stock price forecast at $70.00 and the lowest TNXP stock price forecast at $70.00.

The Wall Street analyst predicted that Tonix Pharmaceuticals Holding's share price could reach $70.00 by Mar 20, 2026. The average Tonix Pharmaceuticals Holding stock price prediction forecasts a potential upside of 292.82% from the current TNXP share price of $17.82.

What is TNXP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's current Earnings Per Share (EPS) is -$176.60. On average, analysts forecast that TNXP's EPS will be -$14.16 for 2025, with the lowest EPS forecast at -$16.43, and the highest EPS forecast at -$11.89. On average, analysts forecast that TNXP's EPS will be -$6.24 for 2026, with the lowest EPS forecast at -$7.80, and the highest EPS forecast at -$4.67. In 2027, TNXP's EPS is forecast to hit -$0.53 (min: -$0.53, max: -$0.53).

What is TNXP's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TNXP) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.